孕期糖尿病和胎儿巨:一个不同意见的意见
Renata Košir Pogačnik1,2, Maja Krajec3, Marija Batkoska1
1Department of Perinatology, Division of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Journal of perinatal medicine
|September 18, 2025
概括
孕产妇怀孕前的肥胖,过度的妊娠期体重增加和平衡是胎儿宏观症 (出生体重>4,000克) 的重要危险因素. 经过良好管理的妊娠糖尿病 (GDM) 不会增加这种风险.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 公共卫生 公共卫生
背景情况:
- 胎儿宏观症,定义为出生体重超过4000克,与不良周产期结果有关.
- 一些母亲的因素,包括肥胖,妊娠期体重增加,平价和妊娠期糖尿病 (GDM),都与胎儿宏观症的发展有关.
研究的目的:
- 调查平价,怀孕前体重指数 (BMI),妊娠期体重增加和GDM对胎儿宏观症发生率的相互作用影响.
- 为了确定胎儿宏观症的独立风险因素.
主要方法:
- 分析了一组基于人口的单子出生数据集,怀孕≥38周.
- 妇女根据怀孕前的BMI (正常与超重/肥胖),平价 (无重与多重),妊娠体重增加 (适当与过重) 和GDM状态 (没有,没有药物治疗或胰岛素治疗) 进行分类.
主要成果:
- 对129,686例分娩的分析显示,过度的妊娠体重增加,妊娠前的BMI>25和平价独立地与胎儿宏观症的风险增加有关.
- 无论如何管理 (非药物或胰岛素),孕期糖尿病 (GDM) 在与没有GDM的女性相比,并未被发现是宏观症的独立风险因素.
结论:
- 有效的GDM管理至关重要,因为它似乎不会对宏观风险作出重大贡献.
- 怀孕前的肥胖,过度的妊娠期体重增加和更高的平价是胎儿过度生长的重要危险因素.
- 强调怀孕前和产前体重管理对于减少胎儿巨症的发病率至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Glucose Transporters
27.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.2K


